CD2 and acute lymphoblastic leukemia: Here we established the combination of CD2+/CD5-/CD13+/CD33-, able to detect 21 of the 24 FLT3mut ETP-ALL patients, as highly sensitive (88%) and specific (95%) algorithm (Table 3).